SANA FY 2023 Earnings — Sana Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

SANASana Biotechnology, Inc.

$900M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$293M

Net Income

-$283M

EPS (Diluted)

$-1.46

Cash Flow

Operating Cash Flow

-$254M

Free Cash Flow

-$274M

Stock-Based Comp.

$36M

Balance Sheet

Total Assets

$565M

Total Liabilities

$278M

Stockholders' Equity

$288M

Cash & Equivalents

$134M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$293M	-$273M	-7.5%
Net Income	-$283M	-$269M	-5.1%